Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics of Lopinavir/Ritonavir”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Testing effectiveness (Phase 2)UnknownNCT01663168
What this trial is testing

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Who this might be right for
HIVTuberculosis
Justine Boles 140
Early research (Phase 1)Study completedNCT00774735
What this trial is testing

GSK1349572 Drug Interaction Study With Protease Inhibitors

Who this might be right for
Healthy SubjectsInfection, Human Immunodeficiency Virus
GlaxoSmithKline 30
Not applicableStudy completedNCT00102986
What this trial is testing

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 116
Early research (Phase 1)Study completedNCT00920088
What this trial is testing

Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs

Who this might be right for
Healthy SubjectsInfection, Human Immunodeficiency Virus
GlaxoSmithKline 24
Testing effectiveness (Phase 2)Study completedNCT01138202
What this trial is testing

Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy

Who this might be right for
HIV InfectionsTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 40
Testing effectiveness (Phase 2)Study completedNCT00400738
What this trial is testing

The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 48
Not applicableStudy completedNCT00179335
What this trial is testing

Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults

Who this might be right for
HIV Infections
Albert Einstein College of Medicine 45
Early research (Phase 1)Study completedNCT01660477
What this trial is testing

Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole

Who this might be right for
Pharmacokinetics of IsavuconazolePharmacokinetics of Lopinavir/RitonavirHealthy Volunteers
Astellas Pharma Global Development, Inc. 68
Testing effectiveness (Phase 2)Study completedNCT01139905
What this trial is testing

Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children

Who this might be right for
HIV-1 Infections
The HIV Netherlands Australia Thailand Research Collaboration 24
Testing effectiveness (Phase 2)Study completedNCT00125983
What this trial is testing

Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 32
Testing effectiveness (Phase 2)Study completedNCT02415985
What this trial is testing

Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly

Who this might be right for
HIVTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 40
Post-approval studies (Phase 4)Study completedNCT01818258
What this trial is testing

IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children

Who this might be right for
HIV PositiveMalnourished
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 52
Post-approval studies (Phase 4)Ended earlyNCT00414284
What this trial is testing

BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)

Who this might be right for
HIV Infections
Community Research Initiative of New England
Large-scale testing (Phase 3)Study completedNCT01196195
What this trial is testing

KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)

Who this might be right for
Antiretroviral Therapy in HIV-1 Infected Children
PENTA Foundation 173
Early research (Phase 1)Study completedNCT00867152
What this trial is testing

GSK1349572 Drug Interaction With Etravirine and Either Darunavir/Ritonavir or Lopinavir/Ritonavir

Who this might be right for
Healthy Volunteer
ViiV Healthcare 17
Early research (Phase 1)Study completedNCT00665951
What this trial is testing

Pharmacokinetic Study of Two Generic Co-formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)

Who this might be right for
HIV Infections
Radboud University Medical Center 12
Post-approval studies (Phase 4)Study completedNCT02348177
What this trial is testing

Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB

Who this might be right for
Acquired Immunodeficiency SyndromeTuberculosis
Drugs for Neglected Diseases 96
Testing effectiveness (Phase 2)Study completedNCT00887120
What this trial is testing

Dose Reduction of Lopinavir in Children

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 24
Early research (Phase 1)Study completedNCT02159352
What this trial is testing

Study Assessing the Effects of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Participants

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 49
Post-approval studies (Phase 4)Study completedNCT00810108
What this trial is testing

Lopinavir/Ritonavir (Kaletra) PK in Children

Who this might be right for
HIV/AIDS TreatmentHIV Infections
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 12
Load More Results